SEARCH RESULTS for assignee:"janssen biotech"

Showing 1 to 20 of 44 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 15898112: TOLL-LIKE RECEPTOR 3 ANTAGONISTS

(A1) 20180179294: TOLL-LIKE RECEPTOR 3 ANTAGONISTS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15312027: PEPTIDE ANTAGONIST OF LL-37

(A1) 20170081378: PEPTIDE ANTAGONIST OF LL-37

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15840281: PD-L1 Binding Fibronectin Type III Domains

(A1) 20180162928: PD-L1 Binding Fibronectin Type III Domains

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15839915: CD8A-Binding Fibronectin Type III Domains

(A1) 20180162927: CD8A-Binding Fibronectin Type III Domains

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15911315: METHOD OF PERFORMING SUBRETINAL DRAINAGE AND AGENT DELIVERY

(A1) 20180256394: METHOD OF PERFORMING SUBRETINAL DRAINAGE AND AGENT DELIVERY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15911315: METHOD OF PERFORMING SUBRETINAL DRAINAGE AND AGENT DELIVERY

(A1) 20180256394: METHOD OF PERFORMING SUBRETINAL DRAINAGE AND AGENT DELIVERY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15911315: METHOD OF PERFORMING SUBRETINAL DRAINAGE AND AGENT DELIVERY

(A1) 20180256394: METHOD OF PERFORMING SUBRETINAL DRAINAGE AND AGENT DELIVERY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15911315: METHOD OF PERFORMING SUBRETINAL DRAINAGE AND AGENT DELIVERY

(A1) 20180256394: METHOD OF PERFORMING SUBRETINAL DRAINAGE AND AGENT DELIVERY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15616016: Bispecific EGFR/C-Met Antibodies

(A1) 20170275367: Bispecific EGFR/C-Met Antibodies

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15798670: Combination Therapies for CD38-Positive Hematological Malignances with ANTI-CD38 Antibodies and Cyclophosphamide

(A1) 20180117150: Combination Therapies for CD38-Positive Hematological Malignances with ANTI-CD38 Antibodies and Cyclophosphamide

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15910392: CO-THERAPY COMPRISING A SMALL MOLECULE CSF-1R INHIBITOR AND AN AGONISTIC ANTIBODY THAT SPECIFICALLY BINDS CD40 FOR THE TREATMENT OF CANCER

(A1) 20180250398: CO-THERAPY COMPRISING A SMALL MOLECULE CSF-1R INHIBITOR AND AN AGONISTIC ANTIBODY THAT SPECIFICALLY BINDS CD40 FOR THE TREATMENT OF CANCER

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 14818864: Antibody Fc Mutants with Ablated Effector Functions

(A1) 20150337053: Antibody Fc Mutants with Ablated Effector Functions

(B2) 1: Antibody Fc Mutants with Ablated Effector Functions

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(B2) 1: Differentiation of Human Embryonic Stem Cells

(X0) 12838998: Differentiation of Human Embryonic Stem Cells

(A1) 20110014163: Differentiation of Human Embryonic Stem Cells

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15319344: BLOCKING CD38 USING ANTI-CD38 F(ab')2 TO PROTECT NK CELLS

(A1) 20180208669: BLOCKING CD38 USING ANTI-CD38 F(ab')2 TO PROTECT NK CELLS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(B2) 1: DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS INTO PANCREATIC ENDOCRINE CELLS

(X0) 13911829: DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS INTO PANCREATIC ENDOCRINE CELLS

(A1) 20130330823: DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS INTO PANCREATIC ENDOCRINE CELLS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15865533: SUPRACHOROIDAL INJECTION DEVICE

(A1) 20180200108: SUPRACHOROIDAL INJECTION DEVICE

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15865533: SUPRACHOROIDAL INJECTION DEVICE

(A1) 20180200108: SUPRACHOROIDAL INJECTION DEVICE

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15865533: SUPRACHOROIDAL INJECTION DEVICE

(A1) 20180200108: SUPRACHOROIDAL INJECTION DEVICE

Assignee(s)